Greenovation Expresses Antibody from Moss

摘要

Private biotech firm Greenovation (Freiburg, Germany) says it has reached a signfiicant milestone in the development of a commercial system to cost-effectively produce humanized monoclonal antibodies from genetically engineered protonema moss.